These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 3325574)

  • 21. Screening of drug resistant strains of Mycobacterium leprae in lepromatous leprosy patients under multidrug treatment.
    Sreevatsa ; Girdhar BK; Desikan KV
    Indian J Med Res; 1988 Feb; 87():139-43. PubMed ID: 3294170
    [No Abstract]   [Full Text] [Related]  

  • 22. A quantitative basis for sustainable anti-Mycobacterium leprae chemotherapy in leprosy control programs.
    Almeida JG
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):255-68. PubMed ID: 1522367
    [No Abstract]   [Full Text] [Related]  

  • 23. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 24. Mouse foot pad technique for evaluation of drug resistance of M. leprae and other laboratory techniques to be used in leprosy control programmes.
    Pattyn SR
    Acta Leprol; 1983; 1(1):29-32. PubMed ID: 6401137
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Minimum inhibitory and bactericidal dosages of rifampici against Mycobacterium leprae in the mouse foot pad: relationship to serum rifampicin concentrations.
    Holmes IB
    Int J Lepr Other Mycobact Dis; 1974; 42(3):289-96. PubMed ID: 4617716
    [No Abstract]   [Full Text] [Related]  

  • 26. Dormancy, drug resistance or dependency; some thoughts to ponder.
    Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
    Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
    [No Abstract]   [Full Text] [Related]  

  • 27. Analysis of quantitative relationship between viability determination in leprosy by MFP, ATP bioluminescence and gene amplification assay.
    Gupta UD; Katoch K; Sharma RK; Singh HB; Natragan M; Singh D; Sharma VD; Chauhan DS; Das R; Srivastava K; Katoch VM
    Int J Lepr Other Mycobact Dis; 2001 Dec; 69(4):328-34. PubMed ID: 12035294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Persisting Mycobacterium leprae among THELEP trial patients in Bamako and Chingleput. Subcommittee on Clinical Trials of the Chemotherapy of Leprosy (THELEP) Scientific Working Group of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.
    Lepr Rev; 1987 Dec; 58(4):325-37. PubMed ID: 3323750
    [No Abstract]   [Full Text] [Related]  

  • 29. Chemotherapeutic trials in leprosy. 5. A study of methods used in clinical trials in lepromatous leprosy.
    Waters MF; Rees RJ; Sutherland I
    Int J Lepr Other Mycobact Dis; 1967; 35(3):311-35. PubMed ID: 4917107
    [No Abstract]   [Full Text] [Related]  

  • 30. Multi-drug therapy in leprosy.
    Girdhar BK
    Indian J Lepr; 1987; 59(2):145-51. PubMed ID: 3309084
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experimental chemotherapy of leprosy].
    Bull World Health Organ; 1976; 54(3):235-44. PubMed ID: 798637
    [No Abstract]   [Full Text] [Related]  

  • 32. Progress in the chemotherapy of leprosy.
    Grosset JH
    Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
    [No Abstract]   [Full Text] [Related]  

  • 33. Prothionamide and prothionamide-S-oxide in experimental leprosy.
    Matsuo Y; Tatsukawa H; Murray JF; Peters JH
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):302-6. PubMed ID: 6459296
    [No Abstract]   [Full Text] [Related]  

  • 34. Chemotherapy of the mycobacterial diseases--leprosy and tuberculosis.
    Krenzien HN
    Indian J Chest Dis Allied Sci; 1982; 24(2-3):223-32. PubMed ID: 6762341
    [No Abstract]   [Full Text] [Related]  

  • 35. [What shall we make of the arrival of "generalized" antibiotics to anti-Hansen's therapy?].
    Decazes JM
    Acta Leprol; 2001-2002; 12(2):61-2. PubMed ID: 12136737
    [No Abstract]   [Full Text] [Related]  

  • 36. Solid, fragmented and granular index as one of the parameters in drug trials.
    Sharma VD; Ramu G; Dutta AK; Katoch K; Ramanathan U
    Lepr India; 1982 Jul; 54(3):448-53. PubMed ID: 6757578
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New trends in the treatment of leprosy].
    Koźmińska-Kubarska A
    Pol Tyg Lek; 1983 Nov; 38(46):1439-41. PubMed ID: 6374636
    [No Abstract]   [Full Text] [Related]  

  • 38. Rifampicin: the investigation of a bactericidal antileprosy drug.
    Rees RJ
    Lepr Rev; 1975 Jun; 46(2 Suppl):121-4. PubMed ID: 1100951
    [No Abstract]   [Full Text] [Related]  

  • 39. Effectiveness of pefloxacin in the treatment of lepromatous leprosy.
    N'Deli L; Guelpa-Lauras CC; Perani EG; Grosset JH
    Int J Lepr Other Mycobact Dis; 1990 Mar; 58(1):12-8. PubMed ID: 2181041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single dose multidrug therapy for single lesion paucibacillry leprosy.
    Salafia A
    Indian J Lepr; 1998; 70(2):216-9; author reply 219-21. PubMed ID: 9724861
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.